Hepatic regeneration in a rat model is impaired by chemotherapy agents used in metastatic colorectal cancer

European Journal of Surgical Oncology

Volumn 41, Issue 11, 2015, Pages 1471-1478

  Hubert, C ^a   Dahrenmoller, C ^a   Marique, L ^a   Jabbour, N ^a   Gianello, P ^b   Leclercq, I ^b  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Bevacizumab; Chemotherapy; Liver regeneration

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BEVACIZUMAB; FLUOROURACIL; MESSENGER RNA; OXALIPLATIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; PLATINUM COMPLEX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; IMMUNOCHEMISTRY; IMMUNODETECTION; LIVER CELL; LIVER HISTOLOGY; LIVER LOBE; LIVER REGENERATION; LIVER WEIGHT; MALE; METASTATIC COLORECTAL CANCER; NONHUMAN; OUTCOME ASSESSMENT; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; RAT; REGENERATIVE ABILITY; SIGNAL TRANSDUCTION; WEIGHT REDUCTION; ANIMAL; COLORECTAL NEOPLASMS; DRUG COMBINATION; DRUG EFFECTS; EXPERIMENTAL NEOPLASM; SECONDARY; WISTAR RAT;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; BEVACIZUMAB; COLORECTAL NEOPLASMS; DRUG THERAPY, COMBINATION; LIVER REGENERATION; MALE; NEOPLASMS, EXPERIMENTAL; ORGANOPLATINUM COMPOUNDS; RATS; RATS, WISTAR;

EID: 84943581109     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2015.08.152     Document Type: Article

References (33)

1. R. Stangl, A. Altendorf-Hofmann, R.M. Charnley, and J. Scheele Factors influencing the natural history of colorectal liver metastases Lancet 343 8910 1994 Jun 4 1405 1410
2. F.G. Fernandez, J.A. Drebin, D.C. Linehan, F. Dehdashti, B.A. Siegel, and S.M. Strasberg Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET) Ann Surg 240 3 2004 Sep 438 447 discussion 447-50
3. E.K. Abdalla, J.-N. Vauthey, L.M. Ellis, and et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases Ann Surg 239 6 2004 Jun 818 825 discussion 825-7
4. T.M. Pawlik, C.R. Scoggins, D. Zorzi, and et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases Ann Surg 241 5 2005 May 715 722 discussion 722-4
5. J. Scheele, R. Stang, A. Altendorf-Hofmann, and M. Paul Resection of colorectal liver metastases World J Surg 19 1 1995 Jan 59 71
6. G. Steele, and T.S. Ravikumar Resection of hepatic metastases from colorectal cancer. Biologic perspective Ann Surg 210 2 1989 Aug 127 138
7. H. Bismuth, R. Adam, F. Levi, and et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy Ann Surg 224 4 1996 Oct 509 520 discussion 520-2
8. F. Levi, R. Zidani, and J.L. Misset Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy Lancet 350 9079 1997 Sep 6 681 686
9. G.A. de, A. Figer, M. Seymour, and et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer J Clin Oncol 18 16 2000 Aug 2938 2947
10. J.Y. Douillard, D. Cunningham, A.D. Roth, and et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial Lancet 355 9209 2000 Mar 25 1041 1047
11. L. Rubbia-Brandt, V. Audard, P. Sartoretti, and et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer Ann Oncol 15 3 2004 Mar 460 466
12. J.-N. Vauthey, T.M. Pawlik, D. Ribero, and et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases J Clin Oncol Am Soc Clin Oncol 24 13 2006 May 1 2065 2072
13. C. Hubert, C. Sempoux, Y. Horsmans, and et al. Nodular regenerative hyperplasia: a deleterious consequence of chemotherapy for colorectal liver metastases? Liver Int 27 7 2007 Sep 938 943 Blackwell Publishing Ltd
14. L. Rubbia-Brandt, G.Y. Lauwers, H. Wang, and et al. Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis Histopathology 56 4 2010 Mar 430 439 Blackwell Publishing Ltd
15. T. Aloia, M. Sebagh, M. Plasse, and et al. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases J Clin Oncol 24 31 2006 Nov 1 4983 4990
16. M. Karoui, C. Penna, M. Amin-Hashem, and et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases Ann Surg 243 1 2006 Jan 1 7
17. H. Nakano, E. Oussoultzoglou, E. Rosso, and et al. Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy Ann Surg 247 1 2008 Jan 118 124
18. Q.-Y. Feng, Y. Wei, J.-W. Chen, and et al. Anti-EGFR and anti-VEGF agents: important targeted therapies of colorectal liver metastases World J Gastroenterol 20 15 2014 Apr 21 4263 4275
19. D. Ribero, H. Wang, M. Donadon, and et al. Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases Cancer 110 12 2007 Dec 15 2761 2767
20. M. Klinger, S. Eipeldauer, S. Hacker, and et al. Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX/FOLFOX therapy of colorectal cancer liver metastases Eur J Surg Oncol 35 5 2009 May 515 520
21. C. Hubert, C. Sempoux, Y. Humblet, and et al. Sinusoidal obstruction syndrome (SOS) related to chemotherapy for colorectal liver metastases: factors predictive of severe SOS lesions and protective effect of bevacizumab HPB (Oxford) 15 11 2013 Jan 18 858 864
22. M. Mahfud, S. Breitenstein, A.M. El-Badry, and et al. Impact of preoperative bevacizumab on complications after resection of colorectal liver metastases: case-matched control study World J Surg 34 1 2010 Jan 92 100
23. M. Bockhorn, M. Goralski, D. Prokofiev, and et al. VEGF is important for early liver regeneration after partial hepatectomy J Surg Res 138 2 2007 Apr 291 299
24. K. Kasuya, M. Suzuki, Y. Nagakawa, and et al. Administration of anti-vascular endothelial growth factor antibody following hepatectomy does not inhibit remnant liver regeneration or growth of remnant metastases Exp Ther Med 3 2 2012 Feb 347 350 Spandidos Publications
25. D. Palmes, and H.-U. Spiegel Animal models of liver regeneration Biomaterials 25 9 2004 Apr 1601 1611
26. Experimental pathology of the liver Arch Pathol 12 1931 186 202 Available from: http://ci.nii.ac.jp/naid/10004477070/
27. M.G. Akritas, S.F. Arnold, and E. Brunner Nonparametric hypotheses and rank statistics for unbalanced factorial designs J Am Stat Assoc 92 437 1997 Mar 258 265
28. T. Gruenberger, W. Scheithauer, C.E. Van, and et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial Lancet 371 2008 1007 1016
29. A. Rickenbacher, M.L. DeOliveira, Y. Tian, and et al. Arguments against toxic effects of chemotherapy on liver injury and regeneration in an experimental model of partial hepatectomy Liver Int 31 3 2011 Mar 313 321 Blackwell Publishing Ltd
30. Extended liver resection after preoperative chemotherapy: influence on regeneration and endoplasmic reticulum stress response Langenbecks Arch Surg 394 4 2009 Jul 681 688 Springer-Verlag. Available from: http://link.springer.com/10.1007/s00423-008-0402-7
31. G. Zafiriou, A. Grekou, P. Stravoravdi, K. Natsis, and A. Barich Histological and ultrastructural study of the effect of chemotherapy with 5-fluorouracil on normal liver of Wistar rats Chemotherapy 48 6 2002 298 302
32. E. Taniguchi, S. Sakisaka, K. Matsuo, K. Tanikawa, and M. Sata Expression and role of vascular endothelial growth factor in liver regeneration after partial hepatectomy in rats J Histochem Cytochem 49 1 2001 Jan 121 130
33. Increased expressions of vascular endothelial growth factor and its receptors, flt-1 and KDR/flk-1, in regenerating rat liver Biochem Biophys Res Commun 226 1 1996 Sep 4 176 179 Available from: http://linkinghub.elsevier.com/retrieve/pii/S0006291X96913297